Cecilia Isaksson

Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

Mohamed A. Kharfan‐Dabaja, Myriam Labopin, Emmanuelle Polge et al. · JAMA Oncology · 2018 · 168 citations · Full text

Medicine, Hematology, Oncology +16

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Joachim Burman, Ellen Iacobaeus, Anders Svenningsson et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 166 citations

Medicine, Hematology, Neurology +14

Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000–2011

Krista Vaht, Magnus Göransson, Kristina Carlson et al. · Haematologica · 2017 · 108 citations · Full text

Medicine, Hematology, Clinical Epidemiology +9

Melphalan 140 mg/m ² or 200 mg/m ² for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party

Holger W. Auner, Simona Iacobelli, Giulia Sbianchi et al. · Haematologica · 2017 · 87 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP

Rayomand Press, Håkan Askmark, Anders Svenningsson et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 61 citations

Medicine, Neurology, Immunopathology +8